Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
3.86 USD | +8.73% | +10.29% | +47.89% |
Kurzporträt
Mitarbeiterzahl: 105
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11.11.20 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 01.12.19 |
Director of Finance/CFO | 46 | 01.12.19 | |
Howard West
CTO | Chief Tech/Sci/R&D Officer | - | 19.10.23 |
Allen Yang
CTO | Chief Tech/Sci/R&D Officer | - | 16.10.23 |
Will Black
CTO | Chief Tech/Sci/R&D Officer | - | - |
Dave Gancarz
PRN | Corporate Officer/Principal | - | - |
Campbell Hair
HRO | Human Resources Officer | - | 01.10.20 |
Urte Gayko
PRN | Corporate Officer/Principal | 53 | 03.11.21 |
Shelley Spray
PRN | Corporate Officer/Principal | 59 | 01.06.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 01.12.19 |
Robert Booth
BRD | Director/Board Member | 70 | 28.09.22 |
Director of Finance/CFO | 46 | 01.12.19 | |
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11.11.20 |
Kenneth Clark
BRD | Director/Board Member | 65 | 07.10.21 |
Director/Board Member | 63 | 15.11.22 | |
Urte Gayko
PRN | Corporate Officer/Principal | 53 | 03.11.21 |
Michelle Xia
BRD | Director/Board Member | 58 | 16.01.23 |
Ujwala Mahatme
BRD | Director/Board Member | 59 | 13.07.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 701 697 179 | 83 407 497 ( 11,89 %) | 0 | 11,89 % |
Unternehmenskontakt
Sektor
Quartalsumsätze - Abweichungsrate
% 1. Jan. | Kap. | |
---|---|---|
+47.89% | 2.71 Mrd. | |
-2.31% | 103 Mrd. | |
+0.56% | 95.28 Mrd. | |
+1.69% | 22.15 Mrd. | |
-17.37% | 21.02 Mrd. | |
-9.30% | 18.15 Mrd. | |
-41.01% | 16.73 Mrd. | |
-14.85% | 16.05 Mrd. | |
+3.21% | 13.68 Mrd. | |
+33.54% | 12.17 Mrd. |
- Börse
- Aktien
- A2QDFS Aktie
- Unternehmen Summit Therapeutics Inc.